Published in Sci Rep on August 04, 2015
Heart rhythm complexity impairment in patients undergoing peritoneal dialysis. Sci Rep (2016) 0.77
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int (2007) 4.68
Pathophysiology of human visceral obesity: an update. Physiol Rev (2013) 4.41
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA (2004) 3.20
The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem (2001) 2.71
A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care (1996) 2.35
Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia (2009) 1.85
Metabolic effects of visceral fat accumulation in type 2 diabetes. J Clin Endocrinol Metab (2002) 1.73
The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant (2003) 1.64
Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol (1994) 1.44
Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol (2010) 1.31
Drugs affecting HbA1c levels. Indian J Endocrinol Metab (2012) 1.08
Visceral fat, arterial stiffness, and endothelial function in peritoneal dialysis patients. J Ren Nutr (2008) 0.99
Visceral fat thickness is associated with carotid atherosclerosis in peritoneal dialysis patients. Obesity (Silver Spring) (2011) 0.98
Risk factors for high dialysate glucose use in PD patients--a retrospective 5-year cohort study. Perit Dial Int (2010) 0.95
Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study. PLoS One (2012) 0.95
Lean body mass predicts long-term survival in Chinese patients on peritoneal dialysis. PLoS One (2013) 0.95
Longitudinal body composition changes due to dialysis. Clin J Am Soc Nephrol (2011) 0.94
Reducing cardiometabolic risk in peritoneal dialysis patients: role of the dialysis solution. J Diabetes Sci Technol (2009) 0.93
Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis. Am J Nephrol (2008) 0.92
Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men. Exp Clin Endocrinol Diabetes (2005) 0.88
Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients. Hypertens Res (2007) 0.88
Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant (1999) 0.87
Glycated hemoglobin predicts mortality in nondiabetic patients receiving chronic peritoneal dialysis. Am J Nephrol (2010) 0.86
Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients. PLoS One (2013) 0.86
Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients. PLoS One (2013) 0.85
Contribution of subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis patients. Nephrol Dial Transplant (2009) 0.84
Glycosylated hemoglobin levels are associated with cardiovascular events in nondiabetic peritoneal dialysis patients. J Nephrol (2012) 0.82
Reduction in adiposity, β-cell function, insulin sensitivity, and cardiovascular risk factors: a prospective study among Japanese with obesity. PLoS One (2013) 0.82
Non-diabetic hyperglycaemia correlates with angiographic coronary artery disease prevalence and severity. Diabetes Metab (2010) 0.82
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis (2013) 0.81
Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic hemodialysis and peritoneal dialysis patients. J Bras Nefrol (2011) 0.78
Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C. Diabetes Res Clin Pract (2011) 0.77